Fertiligent Information

Fertiligent Ltd is a medical device Company with exclusive worldwide rights to EVIE, a patented infertility solution developed by us. EVIE works using slow release insemination, a technique developed to improve the current standard intra-uterine insemination (IUI) often used as an initial infertility treatment worldwide (although it is less common in the UK). A trial of EVIE at 11 fertility centres across Europe was completed in March 2017 and shows EVIE more than doubles a patient's chance of success, compared with standard IUI, in the key under 35 target market (older patients are often encouraged to move directly to IVF). EVIE has all the required EU and US regulatory approvals for sale and is currently raising funds to roll-out EVIE worldwide. Prior to significant fundraising, EVIE has successfully been introduced to selected fertility clinics in the UK and the USA. In the rest of the world, Fertiligent are working to secure key Distributors to cover many European territories, Israel and Singapore.